Page 303 - Demo

General discussion301957. Pekeles H, Accogli A, Boudrahem-Addour N, Russell L, Parente F, Srour M. Diagnostic Yield of Intellectual Disability Gene Panels. Pediatr Neurol. 2019;92. 58. Stefanski A, Calle-López Y, Leu C, Pérez-Palma E, Pestana-Knight E, Lal D. Clinical sequencing yield in epilepsy, autism spectrum disorder, and intellectual disability: A systematic review and meta-analysis. Epilepsia. 2021;62(1). 59. Wang J, Wang Y, Wang L, Chen WY, Sheng M. The diagnostic yield of intellectual disability: Combined whole genome low-coverage sequencing and medical exome sequencing. BMC Med Genomics. 2020;13(1). 60. Coppus AMW. People with intellectual disability: What do we know about adulthood and life expectancy? Vol. 18, Developmental Disabilities Research Reviews. 2013. 61. Stepien KM, Kieć-Wilk B, Lampe C, Tangeraas T, Cefalo G, Belmatoug N, et al. Challenges in Transition From Childhood to Adulthood Care in Rare Metabolic Diseases: Results From the First Multi-Center European Survey. Front Med. 2021;8. 62. Presson AP, Partyka G, Jensen KM, Devine OJ, Rasmussen SA, McCabe LL, et al. Current estimate of down syndrome population prevalence in the United States. J Pediatr. 2013;163(4). 63. Posey JE, Rosenfeld JA, James RA, Bainbridge M, Niu Z, Wang X, et al. Molecular diagnostic experience of whole-exome sequencing in adult patients. Genet Med. 2016;18(7). 64. Yang Y, Muzny DM, Xia F, Niu Z, Person R, Ding Y, et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA - J Am Med Assoc. 2014;312(18). 65. Stunnenberg BC, Deinum J, Nijenhuis T, Huysmans F, van der Wilt GJ, van Engelen BGM, et al. N-of-1 Trials: Evidence-Based Clinical Care or Medical Research that Requires IRB Approval? A Practical Flowchart Based on an Ethical Framework. Healthcare. 2020.66. Cummings J, Montes A, Kamboj S, Cacho JF. The role of basket trials in drug development for neurodegenerative disorders. Vol. 14, Alzheimer’s Research and Therapy. 2022. 67. Park JJH, Hsu G, Siden EG, Thorlund K, Mills EJ. An overview of precision oncology basket and umbrella trials for clinicians. CA Cancer J Clin. 2020;70(2). 68. Atalaia A, Thompson R, Corvo A, Carmody L, Piscia D, Matalonga L, et al. A guide to writing systematic reviews of rare disease treatments to generate FAIR-compliant datasets: Building a Treatabolome. Orphanet J Rare Dis. 2020;15(1). 69. Bonne G. The Treatabolome, an emerging concept. Vol. 8, Journal of Neuromuscular Diseases. 2021. 70. Van Karnebeek CDM, Houben RFA, Lafek M, Giannasi W, Stockler S. The treatable intellectual disability APP www.treatable-id.org: A digital tool to enhance diagnosis & care for rare diseases. Orphanet J Rare Dis. 2012;7(1). 71. Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, et al. The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult selfreported health outcome item banks: 2005-2008. J Clin Epidemiol. 2010;63(11). 72. Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): Progress of an NIH roadmap cooperative group during its first two years. Med Care. 2007;45(5 SUPPL. 1). 73. Nguyen TH, Han HR, Kim MT, Chan KS. An introduction to item response theory for patientreported outcome measurement. Vol. 7, Patient. 2014. 74. Cella D, Gershon R, Lai JS, Choi S. The future of outcomes measurement: Item banking, tailored short-forms, and computerized adaptive assessment. In: Quality of Life Research. 2007. 75. Chang CH. Patient-reported outcomes measurement and management with innovative methodologies and technologies. In: Quality of Life Research. 2007. 76. Khanna D, Krishnan E, Dewitt EM, Khanna PP, Spiegel B, Hays RD. The future of measuring patient-reported outcomes in rheumatology: Patient-Reported Outcomes Measurement Information System (PROMIS). Arthritis Care Res. 2011;63(SUPPL. 11). 77. Thomas ML. Advances in applications of item response theory to clinical assessment. Psychol Assess. 2019;31(12). Annelieke Muller sHL.indd 301 14-11-2023 09:08